Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis

BACKGROUND: The number of clinical studies evaluating the benefit of cytokine-induced killer cell (CIK) therapy, an adoptive immunotherapy, for colorectal cancer (CRC) is increasing. In many of these trials, CIK therapy was coadministered with conventional cancer therapy. The aim of this review is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Celine Man Ying, Tomita, Yoko, Dhakal, Bimala, Li, Runhao, Li, Jun, Drew, Paul, Price, Timothy, Smith, Eric, Maddern, Guy J, Fenix, Kevin Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152003/
https://www.ncbi.nlm.nih.gov/pubmed/37117007
http://dx.doi.org/10.1136/jitc-2023-006764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152003/
https://www.ncbi.nlm.nih.gov/pubmed/37117007
http://dx.doi.org/10.1136/jitc-2023-006764

Ejemplares similares